Updated Jul 16, 2026 · Last SEC filing 2026-07-09
RESMED INC (RMD) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 2 Form 8-K material event filings were reported by RMD in the last 90 days. 4 Form 144 notices of proposed sale were filed for RMD stock. InsiderAlpha tracks every RMD SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Surgical & Medical Instruments & Apparatus (SIC 3841) |
|---|---|
| SEC CIK | 0000943819 |
| Form 4 filings (90d) | 5 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-09 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. | Chairman and CEO | M — Option exercise | 5.0K | $146.34 | $730K | SEC | |
| Farrell Michael J. | Chairman and CEO | S — Open-market sale | 5.0K | $218.55 | $1.09M | SEC | |
| Farrell Michael J. | Chairman and CEO | M — Option exercise | 5.0K | $146.34 | $730K | SEC | |
| Farrell Michael J. | Chairman and CEO | S — Open-market sale | 5.0K | $193.96 | $968K | SEC | |
| Rider Michael J | Global General Counsel | F — Tax withholding / forfeiture | 269 | $190.57 | $51K | SEC | |
| Farrell Michael J. | Chairman and CEO | M — Option exercise | 5.0K | $146.34 | $730K | SEC | |
| Farrell Michael J. | Chairman and CEO | S — Open-market sale | 5.0K | $207.82 | $1.04M | SEC | |
| Farrell Michael J. | Chairman and CEO | M — Option exercise [10b5-1] | 5.0K | $146.34 | $730K | SEC | |
| Farrell Michael J. | Chairman and CEO | S — Open-market sale [10b5-1] | 5.0K | $225.50 | $1.13M | SEC | |
| Sandercock Brett | Chief Financial Officer | S — Open-market sale [10b5-1] | 1.0K | $224.31 | $224K | SEC | |
| FARRELL PETER C | Director | S — Open-market sale [10b5-1] | 2.0K | $225.00 | $450K | SEC | |
| Farrell Michael J. | Chairman and CEO | S — Open-market sale [10b5-1] | 5.0K | $251.03 | $1.25M | SEC | |
| Farrell Michael J. | Chairman and CEO | M — Option exercise [10b5-1] | 5.0K | $146.34 | $730K | SEC | |
| FARRELL PETER C | Director | S — Open-market sale [10b5-1] | 2.0K | $260.22 | $520K | SEC | |
| Sandercock Brett | Chief Financial Officer | S — Open-market sale [10b5-1] | 1.0K | $254.30 | $254K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for RESMED INC (RMD). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Farrell Michael J. | 9 | $5.29M |
| Sandercock Brett | 1 | — |
| Rider Michael J | 1 | $51K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RMD insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live RMD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.